Schedule 13G ownership disclosure

ASCENDIS PHARMA A/S

Security class unavailable · CUSIP: 04351P101

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,859,136
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-094997
Form type
SC 13G
Filer
Ascendis Pharma A/S
CIK
CIK 1612042
Filed
Feb 09, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub